How to Take Meloxicam: Dosage, Timing, and Risks

Meloxicam is taken once daily, usually at the same time each day, with the standard dose ranging from 7.5 mg to 15 mg depending on the condition being treated and individual risk factors. It belongs to the family of nonsteroidal anti-inflammatory drugs (NSAIDs) but differs from older members of the class in ways that affect both its benefits and its risks. Getting the dosage, timing, and risk management right matters more than most people realize, because meloxicam’s long duration in the body means mistakes accumulate rather than wash out quickly.

What Meloxicam Does and Why It Works Differently

Meloxicam reduces pain, swelling, and stiffness by blocking an enzyme called COX-2, which plays a central role in driving inflammation. Most older NSAIDs block both COX-1 and COX-2 without much discrimination. COX-1, though, is the enzyme that helps protect the stomach lining and supports normal kidney blood flow. By preferentially targeting COX-2, meloxicam was designed to deliver anti-inflammatory relief while causing less stomach irritation than traditional options like ibuprofen or naproxen.¹ That selectivity is strongest at lower doses and becomes less pronounced as the dose rises, which is one reason physicians often try the lowest effective dose first.²

This COX-2 preference does not make meloxicam risk-free. It simply shifts the risk profile. The stomach tends to be somewhat better protected at low doses, but cardiovascular and kidney concerns remain. Understanding the drug’s mechanism helps explain why the dosing and timing advice that follows is not arbitrary.

Standard Dosages and When Each Applies

For osteoarthritis, the most common starting dose is 7.5 mg once daily, which can be increased to 15 mg once daily if the lower dose does not provide enough relief. A 12-week trial comparing these doses against placebo found that both 7.5 mg and 15 mg significantly reduced the pain and stiffness of osteoarthritis, with gastrointestinal tolerability comparable to placebo at both dose levels.³ For rheumatoid arthritis, prescribers typically start at 7.5 mg and move to 15 mg as needed. The maximum recommended dose is 15 mg per day; going higher does not improve pain control and sharply increases risk.

For adults 65 and older, current labeling recommends starting at the low end of the dosing range, because older patients face a higher risk of serious cardiovascular, gastrointestinal, and kidney side effects.⁴ In practice, many doctors keep older patients at 7.5 mg indefinitely unless there is a compelling reason to increase.

If you have been prescribed meloxicam for a condition not listed here, the same principle applies: your prescriber chose the dose based on the tradeoff between symptom control and organ-level risk. If 7.5 mg handles your pain adequately, there is little reason to push higher.

Timing, Food, and Consistency

Meloxicam has a long half-life, which is why once-daily dosing works. After you swallow a tablet, the drug reaches its peak blood level within about five to six hours and then clears slowly enough that levels stay therapeutic until the next dose. This long residence time is convenient, but it also means that if you accidentally double up, the excess does not leave your system quickly.

You can take meloxicam with or without food. Taking it with a meal or a glass of water can reduce the chance of stomach upset, so most prescribers suggest taking it with food as a precaution. The timing of day is up to you, but consistency matters. Pick a time you can stick with, whether morning or evening, and take it at roughly the same hour every day. Some patients with morning stiffness from arthritis prefer an evening dose so the drug is near peak levels when they wake up. Others prefer taking it with breakfast so they do not forget. Either approach is reasonable.

Researchers have explored whether timing meloxicam to the body’s circadian inflammatory cycle could improve results, particularly for nighttime application in joint disease.⁵ This concept, sometimes called chronotherapy, is still mostly experimental for meloxicam. For everyday oral use, just being consistent with your chosen time is enough.

Gastrointestinal Risks

Stomach and intestinal bleeding is the risk most people associate with NSAIDs, and meloxicam is not exempt. A systematic review and meta-analysis found that meloxicam carries a significantly elevated risk of gastrointestinal bleeding, though the degree of risk varies widely among individual NSAIDs.⁶ In head-to-head comparisons after knee replacement surgery, the incidence of GI bleeding with meloxicam at 15 mg per day was similar to that of celecoxib, another COX-2-preferring NSAID.⁷

The practical takeaway is that meloxicam’s COX-2 preference does reduce stomach problems compared to fully nonselective NSAIDs at lower doses, but it does not eliminate the risk. If you have a history of ulcers, GI bleeds, or chronic stomach trouble, your doctor may prescribe a proton pump inhibitor alongside meloxicam as a protective measure. Warning signs of GI bleeding include black or tarry stools, vomiting that looks like coffee grounds, persistent stomach pain, and unexplained fatigue or dizziness from blood loss. Any of these warrants immediate medical attention.

Cardiovascular Concerns

All NSAIDs carry cardiovascular warnings, and meloxicam is no exception. A large population-based study found that current meloxicam use was associated with roughly a 38 percent higher odds of heart attack compared to people who had stopped using any NSAID. By comparison, diclofenac showed a similar increase (about 37 percent), while naproxen showed a smaller and statistically insignificant bump (about 12 percent).⁸

These numbers require context. A 38 percent relative increase sounds alarming, but the absolute risk depends on your baseline. If your annual risk of a heart attack is already very low, a 38 percent bump on a small number is still a small number. If you already have heart disease, diabetes, high blood pressure, or other cardiovascular risk factors, that relative increase translates into a meaningful absolute increase. This is why prescribers weigh cardiovascular history heavily when deciding whether meloxicam is appropriate and at what dose.

The general guidance for people with elevated cardiovascular risk is to use the lowest effective dose for the shortest time possible, and to discuss with a prescriber whether naproxen (which appears to have a more favorable cardiovascular profile) might be a better fit. Meloxicam should generally be avoided in the period immediately following coronary artery bypass surgery.

Kidney Effects

NSAIDs reduce blood flow to the kidneys by blocking prostaglandins that help keep the renal arteries dilated. Meloxicam is no different. The spectrum of kidney-related side effects includes fluid retention, worsening of high blood pressure, elevated potassium, and in rare cases, acute kidney injury. One published case described a 65-year-old woman who developed acute tubular necrosis and nephrotic syndrome after taking just 15 mg of meloxicam daily for three days.⁹

That case is dramatic and rare, but it illustrates that kidney injury from meloxicam does not always require months of use. People with pre-existing kidney disease, heart failure, dehydration, or those taking diuretics or blood pressure medications are at the highest risk. For patients with only mild kidney impairment, a 28-day study found that meloxicam at 15 mg daily did not significantly worsen kidney function markers compared to baseline, and the drug did not accumulate to dangerous levels over that period.¹⁰ The distinction matters: mild impairment is often manageable under monitoring, while moderate-to-severe kidney disease generally makes any NSAID a poor choice.

If you are on meloxicam long-term, periodic blood work to check kidney function is standard practice. Staying well-hydrated, especially in hot weather or during exercise, helps protect against the dehydration-plus-NSAID combination that can trigger acute kidney problems.

Drug Interactions Worth Knowing About

Meloxicam interacts with a number of commonly used medications, and some of these interactions are genuinely dangerous.

SSRIs: Antidepressants in the SSRI class (such as fluoxetine, sertraline, and escitalopram) impair platelet function on their own. Combining them with any NSAID, including meloxicam, substantially increases the risk of gastrointestinal bleeding.¹¹ One cohort study found that the combination of an SSRI with an NSAID increased the risk of upper GI bleeding roughly twelvefold compared to the general population.¹² If you take an SSRI and need an anti-inflammatory, your prescriber should know about both medications.
Blood thinners: Warfarin and direct oral anticoagulants are the most concerning. NSAIDs impair platelet aggregation and can erode the GI lining, so adding them to an anticoagulant dramatically raises bleed risk. If you are on a blood thinner and meloxicam is deemed necessary, close monitoring of clotting parameters and possibly adding a stomach-protective drug is standard.
Blood pressure medications: ACE inhibitors, ARBs, and diuretics all interact with NSAIDs. The NSAID blunts the blood-pressure-lowering effect, and the combination can also accelerate kidney damage, particularly in patients who are volume-depleted.
Lithium: NSAIDs reduce the kidney’s ability to clear lithium, potentially pushing lithium blood levels into a toxic range. Lithium levels should be monitored closely if meloxicam is added.
Methotrexate: NSAIDs can slow the clearance of methotrexate, increasing its toxicity. This combination requires careful dose management and monitoring.

The common thread with these interactions is the kidney. Meloxicam alters renal blood flow, and many of the drugs it clashes with either depend on the kidney for clearance or affect the same organ system. If you are prescribed meloxicam alongside any of these medications, the prescriber is presumably aware of the interaction and has decided the benefit outweighs the risk, but it is worth confirming that all your prescribers know your full medication list.

Pregnancy and Breastfeeding

Meloxicam should be avoided during pregnancy, particularly in the second and third trimesters. NSAIDs used during this period can cause premature closure of the ductus arteriosus (a blood vessel in the fetal heart that normally stays open until birth), fetal kidney impairment, and reduced amniotic fluid.¹³ In the third trimester specifically, NSAIDs can also inhibit platelet aggregation and delay labor. The U.S. FDA strengthened its warning on this issue in 2020, extending the caution to cover use at 20 weeks of gestation and beyond, not just the final trimester.

Small amounts of meloxicam pass into breast milk. The clinical significance for the infant is not well established, but most guidelines suggest caution and preferring alternative pain relief when possible during breastfeeding.

How Meloxicam Compares to Other NSAIDs

One of the most practical questions people ask is whether meloxicam is “better” or “safer” than ibuprofen, naproxen, or celecoxib. The honest answer is that no single NSAID is universally superior; each has tradeoffs.

Compared to ibuprofen and naproxen, meloxicam’s once-daily dosing is a genuine convenience advantage. You do not need to remember to take it three times a day. Its COX-2 selectivity may translate into fewer stomach problems at the 7.5 mg dose, though this advantage narrows at 15 mg. On the cardiovascular side, naproxen appears to have a slight edge in heart-attack risk, as the population study noted above found naproxen associated with a smaller, non-significant increase in MI risk compared to meloxicam’s roughly 38 percent increase.⁸

Compared to celecoxib (Celebrex), which is a more selective COX-2 inhibitor, meloxicam performed similarly for GI bleeding and pain control after total knee replacement.⁷ Meloxicam is typically cheaper, which is one reason it remains widely prescribed despite celecoxib being available. Your prescriber’s choice between the two often comes down to insurance coverage, your risk profile, and whether either one has worked well for you in the past.

Alcohol and Meloxicam

Alcohol and NSAIDs both irritate the stomach lining and both stress the liver. Combining them does not produce a dramatic, immediate reaction in most people, but it meaningfully raises the risk of GI bleeding and can compound the burden on your liver and kidneys over time. Occasional light drinking while on meloxicam is a gray area that many prescribers tolerate, but regular or heavy alcohol use alongside any NSAID is genuinely risky. If you drink more than a couple of alcoholic beverages daily, mention it before starting meloxicam.

What to Do If You Miss a Dose

Because meloxicam’s blood levels drop slowly, missing a single dose is not a crisis. If you realize you missed it and your next scheduled dose is many hours away, take it when you remember. If it is close to the time for your next dose, skip the missed one and continue your normal schedule. Do not double up to “catch up.” Doubling the dose raises all the risks described above without meaningfully improving pain control, and the long half-life means the drug hangs around in your body for an extended period at that elevated level.

Meloxicam in Veterinary Medicine

If you have a dog or cat, you may have encountered meloxicam in a veterinary context, because it is one of the most commonly prescribed NSAIDs in animal medicine. The pharmacokinetics in dogs and rats are comparable to those in humans, with similarly high protein binding (above 99 percent in rats and humans).¹⁴ However, species differ considerably in how they metabolize the drug. Cats, for instance, clear meloxicam much more slowly and are highly sensitive to overdose, which is why feline doses are a fraction of canine doses and treatment courses are kept very short.

Accidental overdose in animals does occur. In one reported case, a young Bulldog received roughly ten times the intended dose intravenously after surgery. Aggressive supportive care, including therapeutic plasma exchange over about three and a half hours, achieved an 82 percent reduction in the dog’s plasma meloxicam concentration, and the animal remained symptom-free through follow-up at six weeks.¹⁵ The key takeaway for pet owners is that human meloxicam tablets should never be given to animals without veterinary guidance. The doses are calibrated differently, the formulations differ, and what is safe for a person can be fatal for a small animal.

When to Stop Taking Meloxicam

Unlike corticosteroids, meloxicam does not require a taper. You can stop it abruptly if needed, such as before surgery (most surgeons ask you to stop NSAIDs several days beforehand to reduce bleeding risk) or if you develop side effects. Some people notice that their pain returns within a day or two of stopping, which is normal and expected; meloxicam treats symptoms, not the underlying condition. If you and your prescriber decide to discontinue because of side effects, the drug clears your system over several days, and any NSAID-related kidney or blood pressure effects typically begin reversing within that window.

Long-term use deserves periodic reassessment. If you have been on meloxicam for months or years, it is worth checking in with your prescriber about whether the dose is still appropriate, whether your kidney and cardiovascular status has changed, and whether non-drug approaches like physical therapy, weight management, or joint injections could reduce your need for daily medication. The goal is not to avoid NSAIDs forever, but to make sure you are not taking more than you need for longer than you need it.

1
PubMed. Meloxicam: a selective COX-2 inhibitor non-steroidal anti-inflammatory drug
2
PubMed. Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population
3
JAMA Internal Medicine. Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial
4
Osteoarthritis and Cartilage. Solumatrix meloxicam safety in older patients with osteoarthritis pain
5
PubMed Central. Effect of mechanical properties on the release of meloxicam from poloxamer gel bases
6
PubMed Central. Nonsteroidal Anti-Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis
7
PubMed Central. Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost
8
PubMed Central. Meloxicam and Risk of Myocardial Infarction: A Population-based Nested Case-control Study
9
PubMed. Nephrotic syndrome and acute tubular necrosis due to meloxicam use
10
PubMed. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment
11
European Psychiatry. Review of gastrointestinal bleeding during use of SSRIs combined with use of NSAID
12
PubMed. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study
13
Prescriber Update. Non-steroidal anti-inflammatory drugs (NSAIDs): avoid use in pregnancy
14
PubMed. Pharmacokinetics of meloxicam in animals and the relevance to humans
15
PubMed. Treatment of meloxicam overdose in a dog via therapeutic plasma exchange